Episode 348: ESMO 2024 - UpFrontPSMA

By The Uromigos - Last Updated: September 17, 2024

Arun Azad describes this randomised phase II study of sequential 177Lu-PSMA-617 and docetaxel vs. docetaxel in mHSPC.

Post Tags:Uromigos-ESMOUromigos-Prostate Cancer
Advertisement

Related Podcasts

Episode 377: Prostate Cancer 2024 Highlights
Uromigos-Prostate Cancer
Episode 376: Bladder Cancer 2024 Highlights
Uromigos-Bladder Cancer
Episode 375: Renal Cancer 2024 Highlights
Uromigos-Kidney Cancer
Episode 374: Mechanisms of HIF Resistance
Uromigos-Kidney Cancer
Episode 372: FDA Accelerated Approval Process
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |